Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
Poor quality data has the potential to destroy the validity of a clinical trial, wasting precious...
Source: Tufts Center for the Study of Drug Development
- Press Release
KING OF PRUSSIA, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Featured Article
Participant safety is the clinical trial sector’s top priority – and striving to achieve this laudable...
Source: Applied Clinical Trials
- Press Release
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of...
- Featured Article
The latest version of the Good Clinical Practice (GCP) quality standard insists that sponsors implement a...
Source: Global Forum
- Press Release
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT...
- Featured Article
A risk-based approach to clinical research may include a central statistical assessment of data quality.
...Source: Sage Journals
- Press Release
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational...
- Featured Article
Not only is there a significant good clinical practice (GCP) expectation, Risk-Based Monitoring (RBM) presents a...
Source: Contract Pharma
- Press Release
WAYNE, PA – April 09, 2019: CluePoints, a leading provider of Risk-Based Study Execution(RBx) and Data...
- Featured Article
Since finalizing its risk-based monitoring guidance in 2013, the FDA is providing additional information in a...
Source: Outsourcing Pharma
- Press Release
We’re delighted to announce that registration for CluePoints’ US Risk-Based Quality Management Roadshow is now open....